European Commission gives final approval to AstraZeneca vaccine

Source : 112 Ukraine

Ursula von der Leyen expressed the hope that the company will deliver 400 million doses of vaccine as agreed
08:33, 30 January 2021

Open source

The European Commission gave approval for the use of the Covid-19 vaccine developed by AstraZeneca, the final step to allowing Europe to use it across the Union. This was announced by the head of the European Commission, Ursula von der Leyen, Deutsche welle reports. 

Related: Zelensky appeals to European Commission over lack of COVAX vaccine in Ukraine

"I expect the company to deliver the 400 million doses as agreed," von der Leyen wrote.

Earlier, the European Medicines Agency (EMA) has approved AstraZeneca Covid-19 vaccine for use in the EU. 

The vaccine from AstraZeneca is the third drug approved for use in the EU. Prior to that, the EU allowed the use of vaccines by the German company BioNTech and its American partner Pfizer, as well as a drug from the Moderna concern.

According to experts, the AstraZeneca vaccine is cheaper than the other two manufacturers and has simple storage conditions. At the same time, there is insufficient data on the effectiveness of this vaccine for people over 65 years of age.

The Standing Committee on Vaccination (STIKO) at Germany's Robert Koch Institute (RKI) has already stated that the AstraZeneca vaccine should only be used for people between the ages of 18 and 64.

Related: Ukraine approves coronavirus vaccination plan for 2021: Who and when will be vaccinated



Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

see more